New Age Alpha Advisors, LLC Halozyme Therapeutics, Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.23 Trillion
- Q1 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 25,799 shares of HALO stock, worth $1.37 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
25,799
Previous 28,264
8.72%
Holding current value
$1.37 Million
Previous $1.35 Billion
21.83%
% of portfolio
0.07%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$936 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$682 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$322 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$207 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$195 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.4B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...